Clinical Trial Update: Immunoadsorption in Autoimmune Long COVID [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating immunoadsorption as a treatment for autoimmune Long COVID. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Long COVID, Long COVID Syndrome | Phase 2 | Status: RECRUITING